featured
Spironolactone and Anthracycline-Induced Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
Eur. J. Heart Fail 2014 Nov 20;[EPub Ahead of Print], M Akpek, I Ozdogru, O Sahin, M Inanc, A Dogan, C Yazici, V Berk, H Karaca, N Kalay, A Oguzhan, A ErginFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.